Kinnate Biopharma (KNTE) OrbiMed Advisors - Major Stakeholder OrbiMed Advisors, a leading investment firm, holds a significant stake in Kinnate Biopharma. They currently own 8,009,729 shares of this innovative clinical-stage oncology company, which accounts for 17% of the outstanding stock. On November 13, OrbiMed Advisors, in collaboration with Foresite Capital, submitted an … [Read more...] about Activist Holdings
Footer
